These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 12396797)
1. Measures of quality of life: con. Borasio GD Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S21-3. PubMed ID: 12396797 [No Abstract] [Full Text] [Related]
2. Measures of quality of life: pro. Ludolph AC Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S19. PubMed ID: 12396796 [No Abstract] [Full Text] [Related]
3. Measures of quality of life: summary. Swash M Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S25. PubMed ID: 12396798 [No Abstract] [Full Text] [Related]
4. Therapeutic trials in ALS. Bradley W Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):6-7. PubMed ID: 12745610 [No Abstract] [Full Text] [Related]
5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Miller RG; Mitchell JD; Lyon M; Moore DH Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806 [TBL] [Abstract][Full Text] [Related]
6. Clinical development of levetiracetam for amyotrophic lateral sclerosis. Davies SL; Moral MA Drug News Perspect; 2006 Nov; 19(9):572-3. PubMed ID: 17220961 [TBL] [Abstract][Full Text] [Related]
7. Designing clinical trials in amyotrophic lateral sclerosis. Shefner JM Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):495-508, ix. PubMed ID: 18625412 [TBL] [Abstract][Full Text] [Related]
8. Slowing down ALS--is this good or bad? Munsat TL Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S19-22. PubMed ID: 11465919 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic concepts in Amyotrophic Lateral Sclerosis (ALS)]. Ludolph AC Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S21. PubMed ID: 24242034 [No Abstract] [Full Text] [Related]
11. [Amyotrophic lateral sclerosis. Fatal diagnosis -- how still can be helped?]. Stiefelhagen P MMW Fortschr Med; 2004 Nov; 146(47):16. PubMed ID: 15624649 [No Abstract] [Full Text] [Related]
12. Drug therapy for amyotrophic lateral sclerosis: Where are we now? Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618 [TBL] [Abstract][Full Text] [Related]
13. Assessing quality of life in ALS. Bromberg MB J Clin Neuromuscul Dis; 2007 Dec; 9(2):318-25. PubMed ID: 18090686 [TBL] [Abstract][Full Text] [Related]
14. Vitamin E intake and quality of life in amyotrophic lateral sclerosis patients: a follow-up case series study. Galbussera A; Tremolizzo L; Brighina L; Testa D; Lovati R; Ferrarese C; Cavaletti G; Filippini G Neurol Sci; 2006 Jul; 27(3):190-3. PubMed ID: 16897634 [TBL] [Abstract][Full Text] [Related]
16. Quality of life in amyotrophic lateral sclerosis. Bromberg MB Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):591-605, x-xi. PubMed ID: 18625418 [TBL] [Abstract][Full Text] [Related]
17. Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface. Ludolph AC; Drory VE J Neurol; 2000 Dec; 247 Suppl 6():VI/1. PubMed ID: 19714407 [No Abstract] [Full Text] [Related]
18. [Quality of life in amyotrophic lateral sclerosis]. Bua S Tidsskr Nor Laegeforen; 2007 Aug; 127(16):2126; author reply 2126. PubMed ID: 17717589 [No Abstract] [Full Text] [Related]
19. Commentary on 'a novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS'. Shefner JM; Nigel Leigh P Amyotroph Lateral Scler; 2008 Aug; 9(4):254-6. PubMed ID: 18642137 [No Abstract] [Full Text] [Related]
20. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis. Wicks P; Ganesalingham J; Collin C; Prevett M; Leigh NP; Al-Chalabi A Amyotroph Lateral Scler; 2007 Jun; 8(3):177-9. PubMed ID: 17538780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]